Filing Details
- Accession Number:
- 0001144204-19-026662
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-15 17:16:44
- Reporting Period:
- 2019-05-13
- Accepted Time:
- 2019-05-15 17:16:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1268135 | Arthur Przybyl | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-05-13 | 9,595 | $71.10 | 222,994 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-05-14 | 5,772 | $70.45 | 217,222 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-05-15 | 14,633 | $69.25 | 202,589 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |